HUTCHMED jumps 15% after licensing cancer therapy to GSK for up to $1.295B
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
We can finally ensure 500,000 miners are paid out for silicosis and TB — here’s the problem
Nearly half a million miners are owed compensation for silicosis and tuberculosis claims but getting the money to them and their families is still a hard journey.
Act for Nutrition conference: WB official calls for understanding WASH-related drivers of malnutrition
The second day of a two-day international conference, ‘Act For Nutrition: The Emergency We Can No Longer Ignore’, is being held at Islamabad’s Serena Hotel.
Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone
This biotech stock looks like a great candidate to buy on the admittedly steep dip.
Mar Thoma Church trustee’s call for mandatory HIV test before marriage sparks debate
During a family meet recently, Rev. K. Thomas said he favoured a system under which marriages in Mar Thoma Church would be solemnised only after prospective bride and groom had undergone HIV tests
New maternal units commissioned in North Tongu to improve access to care
Access to safer and more dignified maternal and child healthcare is expected to improve in North Tongu following the commissioning of two new 15-bed Mother and Child Health Units at the Volo and…
An ageing India, counted but not fully understood
To serve our elderly population adequately, we need to know more than simply how many people are eligible for health insurance schemes: we need to know what chronic conditions they live with, how much…